Impact of heart failure drug therapy on rates of gastrointestinal bleeding in LVAD recipients: An INTERMACS analysis

Introduction: Gastrointestinal bleeding (GIB) remains a common and vexing complication of left ventricular assist device (LVAD) support. Recent single-center analyses suggest that ACE inhibitors (ACEi)/angiotensin receptor blockers (ARB) and digoxin may prevent GIB in LVAD patients. Here we evaluate...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of artificial organs 2021-12, Vol.44 (12), p.965-971
Hauptverfasser:	Jennings, Douglas L, Truby, Lauren K, Littlefield, Audrey J, Ciolek, Alana M, Marshall, Dylan, Jain, Rashmi, Topkara, Veli K
Format:	Artikel
Sprache:	eng
Schlagworte:	Amiodarone Angiotensin Receptor Antagonists - therapeutic use Angiotensin-converting enzyme inhibitors Angiotensin-Converting Enzyme Inhibitors - therapeutic use Anticoagulants Antiplatelet therapy Bleeding Chemotherapy Congestive heart failure Digoxin Diuretics Drug therapy Etiology Gastrointestinal Hemorrhage - chemically induced Heart failure Heart Failure - therapy Heart-Assist Devices - adverse effects Humans Inhibitors Mathematical analysis Patients Receptors Renal function Retrospective Studies Risk Ventricle
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!